OverviewSuggest Edit

Bringing Aesica together with Bespak within the Consort Medical group builds on Bespak’s rich drug delivery device heritage over the last 50 years and Aesica’s decade-long expansion into a leading European pharmaceutical CDMO. Today, Consort Medical is a leading, global, single source drug and delivery device CDMO. Optimising world-class drug delivery device development and manufacture, together with API and finished dose drug formulation and manufacture, within the same group streamlines and accelerates our pharmaceutical customers’ drug route to market. Consort Medical remains at the leading edge of innovation and is committed to investing in patient- and customer-driven innovation with the potential to create new treatments, new markets and new opportunities.

TypePublic
HQHemel Hempstead, GB
Websiteconsortmedical.com
Employee Ratings4

Latest Updates

Employees (est.) (Oct 2017)2,098(+6%)
Revenue (FY, 2019)£305.1 M(-1%)
Share Price (Oct 2017)£11.1 (-1%)
Cybersecurity ratingAMore

Key People/Management at Consort Medical

Jonathan Glenn

Jonathan Glenn

CEO
Paul Hayes

Paul Hayes

CFO
Lisa King

Lisa King

Director of Human Resources
Keyvan Djamarani

Keyvan Djamarani

Business President, Bespak
Manja Boerman

Manja Boerman

Business President, Aesica
Show more

Consort Medical Office Locations

Consort Medical has offices in Hemel Hempstead, Cambridge, Cramlington, King’s Lynn and in 6 other locations
Hemel Hempstead, GB (HQ)
39 Breakspear Way
Cambridge, GB
6-7 Technopark Newmarket Road
Cramlington, GB
Windmill Industrial Estate Shotton Lane
King’s Lynn, GB
Bergen Way
Milton Keynes , GB
Blackhill Drive
Nelson, GB
Edward Street
Show all (10)

Consort Medical Financials and Metrics

Consort Medical Revenue

Consort Medical's revenue was reported to be £305.10 m in FY, 2019
GBP

Revenue (FY, 2019)

305.1m

Net income (FY, 2019)

10.5m

EBIT (FY, 2019)

15.6m

Market capitalization (31-Oct-2017)

542.9m

Closing stock price (31-Oct-2017)

11.1

Cash (30-Apr-2019)

13.5m

EV

640.5m
Consort Medical's current market capitalization is £542.9 m.
GBPFY, 1996FY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

76.2m77.7m86.1m81.9m83.0m78.7m91.0m88.3m83.2m79.4m93.1m126.5m133.0m95.0m100.0m184.8m276.9m294.0m311.1m305.1m

Revenue growth, %

85%50%

Cost of goods sold

176.7m

Gross profit

8.2m
GBPFY, 1996FY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

9.4m16.0m6.5m8.6m2.3m190.0k2.9m1.7m2.2m5.1m9.8m17.3m18.3m37.0m25.8m45.2m16.2m22.2m21.4m13.5m

Accounts Receivable

13.4m10.3m13.0m11.0m10.3m11.0m8.4m10.8m9.1m11.5m14.4m13.0m15.4m5.6m13.6m47.0m45.2m43.2m55.5m53.6m

Inventories

8.2m5.8m4.2m3.4m3.2m3.5m3.4m3.5m6.0m6.1m9.6m10.5m8.7m11.7m10.2m31.3m30.7m34.4m35.2m47.1m

Current Assets

32.3m34.0m34.4m29.1m34.0m35.7m47.9m34.3m36.6m41.0m38.9m47.3m48.0m71.5m64.0m139.1m110.8m122.2m132.0m130.4m
GBPFY, 1996FY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

16.0m7.4m10.1m12.4m(18.8m)11.0m11.0m2.8m6.6m2.7m10.3m11.4m2.6m10.9m13.6m6.3m16.0m22.6m16.1m

Cash From Operating Activities

13.8m17.9m21.7m20.4m17.7m20.1m27.7m3.0m13.2m14.2m13.4m26.2m20.4m20.0m13.8m12.1m36.7m40.7m32.4m34.6m

Cash From Investing Activities

(23.4m)

Dividends Paid

2.8m3.1m3.5m3.9m4.4m4.8m5.1m5.1m5.1m5.1m5.2m5.4m5.5m5.5m5.8m7.0m
GBPFY, 1996

Financial Leverage

2.1 x
Show all financial metrics

Consort Medical Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Consort Medical Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

Consort Medical Online and Social Media Presence

Embed Graph

Consort Medical News and Updates

Consort Medical Frequently Asked Questions

  • Who are Consort Medical key executives?

    Consort Medical's key executives are Jonathan Glenn, Paul Hayes and Lisa King.

  • How many employees does Consort Medical have?

    Consort Medical has 2,098 employees.

  • What is Consort Medical revenue?

    Latest Consort Medical annual revenue is £305.1 m.

  • What is Consort Medical revenue per employee?

    Latest Consort Medical revenue per employee is £145.4 k.

  • Who are Consort Medical competitors?

    Competitors of Consort Medical include Alexza Pharmaceuticals, Jazz Pharmaceuticals and Hikma Pharmaceuticals.

  • Where is Consort Medical headquarters?

    Consort Medical headquarters is located at 39 Breakspear Way, Hemel Hempstead.

  • Where are Consort Medical offices?

    Consort Medical has offices in Hemel Hempstead, Cambridge, Cramlington, King’s Lynn and in 6 other locations.

  • How many offices does Consort Medical have?

    Consort Medical has 10 offices.